CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 43 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,323,000 | +0.2% | 235,214 | 0.0% | 0.03% | +3.0% |
| Q3 2020 | $4,314,000 | +22.5% | 235,214 | 0.0% | 0.03% | +3.1% |
| Q2 2020 | $3,521,000 | -5.4% | 235,214 | 0.0% | 0.03% | -36.0% |
| Q1 2020 | $3,721,000 | -2.6% | 235,214 | 0.0% | 0.05% | +4.2% |
| Q4 2019 | $3,820,000 | +9.3% | 235,214 | 0.0% | 0.05% | 0.0% |
| Q3 2019 | $3,495,000 | – | 235,214 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|